HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Chen Selected Research

Aftercare (After-Treatment)

4/2022[The efficacy of eltrombopag plus cyclosporine A in patients with transfusion-dependent non-severe aplastic anemia: a retrospective study from single center].
2/2022Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib.
10/2020MiR-513a-3p inhibits EMT mediated by HOXB7 and promotes sensitivity to cisplatin in ovarian cancer cells.
7/2020[Clinical characteristics of SLC35A2 gene variants related congenital disorders of glycosylation typeⅡ].
9/2019Efficacy of low-level laser therapy in pain management after root canal treatment or retreatment: a systematic review.
10/2018[Observation on the effects of multidisciplinary comprehensive intervention in integrated treatment of patients with extremely severe burns].
9/2018[Comparison of the short-term and long-term curative effect and prognosis of 102 patients with sudden deafness].
6/2017[Surgical treatment of severe, refractory hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation: a report of 17 patients].
12/2016Ten-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-α and ribavirin therapy.
2/2016Clinical features, treatment and outcomes of vaginal intraepithelial neoplasia in a Chinese tertiary centre.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Chen Research Topics

Disease

268Neoplasms (Cancer)
06/2022 - 01/2000
63Infections
10/2022 - 01/2000
57Inflammation (Inflammations)
02/2022 - 01/2000
34Breast Neoplasms (Breast Cancer)
02/2021 - 05/2000
33Carcinoma (Carcinomatosis)
01/2020 - 02/2000
29Neoplasm Metastasis (Metastasis)
01/2022 - 01/2000
27Lung Neoplasms (Lung Cancer)
06/2021 - 01/2000
26Hepatocellular Carcinoma (Hepatoma)
11/2021 - 02/2000
24Carcinogenesis
06/2021 - 08/2001
24Prostatic Neoplasms (Prostate Cancer)
01/2021 - 06/2000
22Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2000
22Hypoxia (Hypoxemia)
10/2020 - 01/2001
21Pain (Aches)
03/2022 - 01/2000
21Necrosis
10/2021 - 06/2000
20Fibrosis (Cirrhosis)
07/2021 - 01/2000
19Stroke (Strokes)
02/2020 - 02/2000
18Asthma (Bronchial Asthma)
02/2022 - 07/2000
18Wounds and Injuries (Trauma)
09/2021 - 04/2000
18Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 08/2000
17Hypertension (High Blood Pressure)
03/2022 - 11/2000
16Hemorrhage
02/2022 - 06/2000
15Body Weight (Weight, Body)
01/2022 - 08/2000
15Ischemia
04/2021 - 06/2000
15Alzheimer Disease (Alzheimer's Disease)
01/2021 - 12/2000
14Melanoma (Melanoma, Malignant)
10/2021 - 03/2000
14Burns
01/2021 - 04/2000
14Leukemia
02/2018 - 01/2000
13Atherosclerosis
11/2021 - 01/2000
13Mitochondrial Diseases (Mitochondrial Disease)
10/2020 - 02/2001
13Obesity
05/2020 - 09/2000
12Sepsis (Septicemia)
04/2022 - 02/2001
12Thrombosis (Thrombus)
06/2021 - 03/2000
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 06/2000
12Stomach Neoplasms (Stomach Cancer)
01/2019 - 10/2000
11Hypersensitivity (Allergy)
02/2022 - 01/2001
11Nasopharyngeal Carcinoma
12/2021 - 07/2001
10Proteinuria
10/2021 - 03/2001
10Heart Failure
10/2021 - 06/2000
10Adenocarcinoma
08/2021 - 06/2000
10Myocardial Infarction
02/2021 - 04/2001
10Lymphoma (Lymphomas)
01/2021 - 03/2001
10Insulin Resistance
01/2020 - 03/2000
9Diabetes Mellitus
11/2021 - 04/2000
9Fever (Fevers)
01/2021 - 05/2000
9Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 09/2010
9Tuberculosis (Tuberculoses)
05/2020 - 08/2001
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 12/2001
9Human Influenza (Influenza)
07/2018 - 06/2000
9Brain Ischemia (Cerebral Ischemia)
01/2018 - 09/2000

Drug/Important Bio-Agent (IBA)

113Proteins (Proteins, Gene)FDA Link
04/2022 - 01/2000
46Messenger RNA (mRNA)IBA
12/2021 - 01/2000
44CytokinesIBA
09/2022 - 01/2000
36Pharmaceutical PreparationsIBA
03/2022 - 09/2000
33DNA (Deoxyribonucleic Acid)IBA
12/2021 - 02/2000
22Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 04/2000
22Biological ProductsIBA
10/2020 - 06/2000
20Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2000
18Long Noncoding RNAIBA
06/2022 - 01/2016
18Peptides (Polypeptides)IBA
04/2022 - 01/2001
18VaccinesIBA
02/2022 - 11/2000
18Therapeutic UsesIBA
08/2021 - 01/2000
18EnzymesIBA
07/2021 - 07/2000
17CholesterolIBA
07/2020 - 09/2000
17AntigensIBA
07/2018 - 01/2000
16RNA (Ribonucleic Acid)IBA
06/2021 - 02/2001
16MicroRNAs (MicroRNA)IBA
08/2019 - 07/2007
15AntibodiesIBA
06/2021 - 03/2000
15Small Interfering RNA (siRNA)IBA
09/2019 - 12/2006
15Complementary DNA (cDNA)IBA
01/2016 - 02/2000
14Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 11/2000
14Phosphotransferases (Kinase)IBA
02/2022 - 06/2006
14Interleukin-6 (Interleukin 6)IBA
12/2021 - 03/2001
13Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2000
13CreatinineIBA
11/2021 - 06/2000
13LipidsIBA
11/2021 - 03/2000
13Glucose (Dextrose)FDA LinkGeneric
11/2021 - 09/2000
13Oxygen (Dioxygen)IBA
04/2021 - 01/2001
13Transcription Factors (Transcription Factor)IBA
01/2021 - 06/2000
13Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017 - 01/2003
11LigandsIBA
01/2021 - 04/2000
11Insulin (Novolin)FDA Link
01/2020 - 03/2000
10salicylhydroxamic acid (SHAM)IBA
06/2022 - 04/2000
10Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2001
10CollagenIBA
11/2021 - 08/2000
10Adenosine Triphosphate (ATP)IBA
10/2020 - 06/2000
10Blood Glucose (Blood Sugar)IBA
09/2020 - 08/2000
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 07/2001
10AcidsIBA
11/2018 - 07/2000
9Caspase 3 (Caspase-3)IBA
08/2021 - 04/2010
9InterleukinsIBA
01/2021 - 04/2010
9Hormones (Hormone)IBA
01/2021 - 06/2001
9Retinaldehyde (Retinal)IBA
10/2019 - 09/2000

Therapy/Procedure

104Therapeutics
02/2022 - 01/2000
36Drug Therapy (Chemotherapy)
01/2022 - 01/2000
21Radiotherapy
01/2020 - 01/2000
20Transplantation
05/2021 - 09/2004
19Aftercare (After-Treatment)
04/2022 - 04/2000
11Hematopoietic Stem Cell Transplantation
10/2020 - 08/2005
10Immunotherapy
01/2021 - 07/2000
9Stents
02/2020 - 06/2007